Senior healthcare leaders and board members routinely ask us the following two questions.

Assessing the future of healthcare price transparency requires taking a couple of steps back to review its recent history.

The hospital and health system leaders we work with are extremely concerned about the financial impact their organizations may experience from potentially significant Medicaid policy changes, following the recent passage of a budget resolution by the U.S. House of Representatives.

Possible limitations on state directed payment programs could have a significant impact on many hospitals’ bottom line. Organizations should act now to model the impact and identify steps that could help mitigate it.

The impact of federal policy changes on not-for-profit healthcare was the focus of Kaufman Hall’s 2025 Spring Rating Agency update. Our panelists from Fitch, Moody’s and S&P Global discussed potential cuts to the Medicaid program, site neutral payments, the tax-exempt status of private activity bonds and tariffs and supply chain challenges.

A conversation with Rich Liekweg, CEO of BJC Health System in Missouri, and Nick Barto, president of BJC Health System

Downgrades continued to outpace upgrades in 2024 although at a lower rate than in 2023. Many of the downgrades reflected ongoing expense pressure that exceeded revenue growth. Rating affirmations remained the majority rating action in 2024, as in prior years.